{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:32:24Z","timestamp":1781706744395,"version":"3.54.5"},"reference-count":163,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Influenza is a viral respiratory disease causing seasonal epidemics, with significant annual illness and mortality. Emerging viruses can pose a major pandemic threat if they acquire the capacity for sustained human-to-human transmission. Vaccination reduces influenza-associated mortality and is critical in minimising the burden on the healthcare system. However, current vaccines are not always effective in at-risk populations and fail to induce long-lasting protective immunity against a range of viruses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>The development of \u2018universal\u2019 influenza vaccines, which induce heterosubtypic immunity capable of reducing disease severity, limiting viral shedding or protecting against influenza subtypes with pandemic potential, has gained interest in the research community. To date, approaches have focused on inducing immune responses to conserved epitopes within the stem of haemagglutinin, targeting the ectodomain of influenza M2e or by stimulating cellular immunity to conserved internal antigens, nucleoprotein or matrix protein 1.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Adenoviral vectors are potent inducers of T-cell and antibody responses and have demonstrated safety in clinical applications, making them an excellent choice of vector for delivery of vaccine antigens. In order to circumvent pre-existing immunity in humans, serotypes from non-human primates have recently been investigated. We will discuss the pre-clinical development of these novel vectors and their advancement to clinical trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jphp.12350","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T04:49:24Z","timestamp":1420519764000},"page":"382-399","source":"Crossref","is-referenced-by-count":23,"title":["Adenoviral vectors as novel vaccines for influenza"],"prefix":"10.1093","volume":"67","author":[{"given":"Lynda","family":"Coughlan","sequence":"first","affiliation":[{"name":"The Jenner Institute, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Mullarkey","sequence":"additional","affiliation":[{"name":"The Jenner Institute, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gilbert","sequence":"additional","affiliation":[{"name":"The Jenner Institute, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,1]]},"reference":[{"key":"2024103012540464600_jphp12350-cit-0001","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0002","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"2024103012540464600_jphp12350-cit-0003","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","article-title":"Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly","volume":"61","author":"de Jong","year":"2000","journal-title":"J Med Virol"},{"key":"2024103012540464600_jphp12350-cit-0004","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2119\/molmed.2012.00147","article-title":"Novel viral vectored vaccines for the prevention of influenza","volume":"18","author":"Lambe","year":"2012","journal-title":"Mol Med"},{"key":"2024103012540464600_jphp12350-cit-0005","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1086\/648406","article-title":"Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial","volume":"200","author":"Beran","year":"2009","journal-title":"J Infect Dis"},{"issue":"2","key":"2024103012540464600_jphp12350-cit-0006","article-title":"Vaccines for preventing influenza in healthy adults","author":"Jefferson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2024103012540464600_jphp12350-cit-0007","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004879.pub3","article-title":"Vaccines for preventing influenza in healthy children","author":"Jefferson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2024103012540464600_jphp12350-cit-0008","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1128\/JVI.05213-11","article-title":"Annual vaccination against influenza virus hampers development of virus-specific CD8(+) T cell immunity in children","volume":"85","author":"Bodewes","year":"2011","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/v2010166","article-title":"Targets for the induction of protective immunity against influenza a viruses","volume":"2","author":"Bodewes","year":"2010","journal-title":"Viruses"},{"key":"2024103012540464600_jphp12350-cit-0011","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"2024103012540464600_jphp12350-cit-0012","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1637\/8903-042909-Reg.1","article-title":"Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt","volume":"54","author":"Balish","year":"2010","journal-title":"Avian Dis"},{"key":"2024103012540464600_jphp12350-cit-0013","doi-asserted-by":"crossref","first-page":"16936","DOI":"10.1073\/pnas.0608157103","article-title":"Emergence and predominance of an H5N1 influenza variant in China","volume":"103","author":"Smith","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024103012540464600_jphp12350-cit-0014","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1073\/pnas.0511120103","article-title":"Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024103012540464600_jphp12350-cit-0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00037-06","article-title":"Avian influenza virus (H5N1): a threat to human health","volume":"20","author":"Peiris","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2024103012540464600_jphp12350-cit-0016","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2012.162","article-title":"Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery","volume":"20","author":"Coughlan","year":"2012","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0017","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"Penaloza-MacMaster","year":"2013","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0018","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/infdis\/jis670","article-title":"First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)","volume":"207","author":"Baden","year":"2013","journal-title":"J Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0019","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/infdis\/jis671","article-title":"Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)","volume":"207","author":"Barouch","year":"2013","journal-title":"J Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0020","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jir850","article-title":"Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector","volume":"205","author":"O'Hara","year":"2012","journal-title":"J Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0021","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens","volume":"22","author":"Antrobus","year":"2013","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0022","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2010.519332","article-title":"Production of adenovirus vectors and their use as a delivery system for influenza vaccines","volume":"10","author":"Vemula","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"2024103012540464600_jphp12350-cit-0023","doi-asserted-by":"crossref","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci Transl Med"},{"key":"2024103012540464600_jphp12350-cit-0024","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/v2102290","article-title":"Tropism-modification strategies for targeted gene delivery using adenoviral vectors","volume":"2","author":"Coughlan","year":"2010","journal-title":"Viruses"},{"key":"2024103012540464600_jphp12350-cit-0025","first-page":"227","article-title":"Family adenoviridae","volume-title":"Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses","author":"Benk\u0151","year":"2000"},{"key":"2024103012540464600_jphp12350-cit-0026","first-page":"2355","article-title":"Adenoviridae: the viruses and their replication","volume-title":"Fields' Virology","author":"Martin","year":"2007","edition":"5th edn"},{"key":"2024103012540464600_jphp12350-cit-0027","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/514978","article-title":"Disseminated adenovirus disease in immunocompromised and immunocompetent children","volume":"27","author":"Munoz","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0028","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1128\/JVI.00445-09","article-title":"In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery","volume":"83","author":"Coughlan","year":"2009","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0029","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1158\/0008-5472.CAN-08-1145","article-title":"Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency","volume":"68","author":"Gros","year":"2008","journal-title":"Cancer Res"},{"key":"2024103012540464600_jphp12350-cit-0030","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/gt.2011.184","article-title":"GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution","volume":"19","author":"Guedan","year":"2012","journal-title":"Gene Ther"},{"key":"2024103012540464600_jphp12350-cit-0031","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1089\/hum.2011.218","article-title":"Combined fiber modifications both to target alpha(v)beta(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5","volume":"23","author":"Coughlan","year":"2012","journal-title":"Hum Gene Ther"},{"key":"2024103012540464600_jphp12350-cit-0032","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0994-42","article-title":"Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis","volume":"8","author":"Crystal","year":"1994","journal-title":"Nat Genet"},{"key":"2024103012540464600_jphp12350-cit-0033","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol Genet Metab"},{"key":"2024103012540464600_jphp12350-cit-0034","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.gt.3301047","article-title":"New tools for the generation of E1- and\/or E3-substituted adenoviral vectors","volume":"7","author":"Danthinne","year":"2000","journal-title":"Gene Ther"},{"key":"2024103012540464600_jphp12350-cit-0036","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1475-2875-11-209","article-title":"Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naive and adenovirus (Ad5) immune mice","volume":"11","author":"Schuldt","year":"2012","journal-title":"Malar J"},{"key":"2024103012540464600_jphp12350-cit-0037","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/JVI.02055-12","article-title":"Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0038","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"Barouch","year":"2011","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0039","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"2024103012540464600_jphp12350-cit-0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"key":"2024103012540464600_jphp12350-cit-0041","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.0900537","article-title":"Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination","volume":"184","author":"Holst","year":"2010","journal-title":"J Immunol"},{"key":"2024103012540464600_jphp12350-cit-0042","doi-asserted-by":"crossref","first-page":"147ra114","DOI":"10.1126\/scitranslmed.3004273","article-title":"Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure","volume":"4","author":"Wei","year":"2012","journal-title":"Sci Transl Med"},{"key":"2024103012540464600_jphp12350-cit-0043","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/hum.2013.215","article-title":"CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy","volume":"25","author":"Camacho","year":"2014","journal-title":"Hum Gene Ther"},{"key":"2024103012540464600_jphp12350-cit-0044","doi-asserted-by":"crossref","first-page":"e73313","DOI":"10.1371\/journal.pone.0073313","article-title":"Low seroprevalent species D adenovirus vectors as influenza vaccines","volume":"8","author":"Weaver","year":"2013","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0045","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0046","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J Immunol"},{"key":"2024103012540464600_jphp12350-cit-0047","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"2024103012540464600_jphp12350-cit-0048","doi-asserted-by":"crossref","first-page":"115ra1","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"2024103012540464600_jphp12350-cit-0049","doi-asserted-by":"crossref","first-page":"e41936","DOI":"10.1371\/journal.pone.0041936","article-title":"A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults","volume":"7","author":"Keefer","year":"2012","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0050","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1128\/JVI.75.23.11603-11613.2001","article-title":"Replication-defective vector based on a chimpanzee adenovirus","volume":"75","author":"Farina","year":"2001","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0051","doi-asserted-by":"crossref","first-page":"e55435","DOI":"10.1371\/journal.pone.0055435","article-title":"Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus","volume":"8","author":"Vitelli","year":"2013","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0052","doi-asserted-by":"crossref","first-page":"e1000503","DOI":"10.1371\/journal.ppat.1000503","article-title":"Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates","volume":"5","author":"Roy","year":"2009","journal-title":"PLoS Pathog"},{"key":"2024103012540464600_jphp12350-cit-0053","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"Bradley","year":"2012","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0054","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.virol.2004.03.047","article-title":"Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses","volume":"324","author":"Roy","year":"2004","journal-title":"Virology"},{"key":"2024103012540464600_jphp12350-cit-0055","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/mt.2011.176","article-title":"Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors","volume":"19","author":"Sheehy","year":"2011","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0056","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"2024103012540464600_jphp12350-cit-0057","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1089\/hum.1998.9.13-1909","article-title":"New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses","volume":"9","author":"Fallaux","year":"1998","journal-title":"Hum Gene Ther"},{"key":"2024103012540464600_jphp12350-cit-0058","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"Reyes-Sandoval","year":"2010","journal-title":"Infect Immun"},{"key":"2024103012540464600_jphp12350-cit-0059","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.vaccine.2010.10.041","article-title":"Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates","volume":"29","author":"Capone","year":"2010","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0060","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/eji.200737672","article-title":"Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei","volume":"38","author":"Reyes-Sandoval","year":"2008","journal-title":"Eur J Immunol"},{"key":"2024103012540464600_jphp12350-cit-0061","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/JVI.02568-07","article-title":"Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A","volume":"82","author":"Sridhar","year":"2008","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0062","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","article-title":"A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag","volume":"170","author":"Fitzgerald","year":"2003","journal-title":"J Immunol"},{"key":"2024103012540464600_jphp12350-cit-0063","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1128\/JVI.78.14.7392-7399.2004","article-title":"Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes","volume":"78","author":"Reyes-Sandoval","year":"2004","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0064","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ymthe.2006.03.027","article-title":"A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus","volume":"14","author":"Zhou","year":"2006","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0065","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"Borthwick","year":"2013","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0066","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.00866-09","article-title":"Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization","volume":"84","author":"Cheng","year":"2010","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0067","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JVI.06254-11","article-title":"Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection","volume":"86","author":"Bradley","year":"2012","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0068","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.75.10.4792-4801.2001","article-title":"\u2018Stealth\u2019 adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung","volume":"75","author":"Croyle","year":"2001","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0069","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2004.07.043","article-title":"Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans","volume":"23","author":"Van Kampen","year":"2005","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0071","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0072","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature07231","article-title":"Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors","volume":"455","author":"Yu","year":"2008","journal-title":"Nature"},{"issue":"Pt 9","key":"2024103012540464600_jphp12350-cit-0073","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1099\/vir.0.82867-0","article-title":"The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein","volume":"88","author":"Onion","year":"2007","journal-title":"J Gen Virol"},{"key":"2024103012540464600_jphp12350-cit-0074","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI60202","article-title":"Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine","volume":"122","author":"Frahm","year":"2012","journal-title":"J Clin Invest"},{"key":"2024103012540464600_jphp12350-cit-0075","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood-2004-02-0646","article-title":"Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells","volume":"104","author":"Leen","year":"2004","journal-title":"Blood"},{"key":"2024103012540464600_jphp12350-cit-0076","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nm.1991","article-title":"Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans","volume":"15","author":"O'Brien","year":"2009","journal-title":"Nat Med"},{"key":"2024103012540464600_jphp12350-cit-0077","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.vaccine.2009.10.091","article-title":"Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive","volume":"28","author":"Hutnick","year":"2010","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0078","doi-asserted-by":"crossref","first-page":"e14385","DOI":"10.1371\/journal.pone.0014385","article-title":"Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality","volume":"5","author":"Hutnick","year":"2010","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0079","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1073\/pnas.1400446111","article-title":"Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals","volume":"111","author":"Hu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024103012540464600_jphp12350-cit-0080","doi-asserted-by":"crossref","first-page":"19940","DOI":"10.1073\/pnas.0907898106","article-title":"Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1","volume":"106","author":"Benlahrech","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024103012540464600_jphp12350-cit-0081","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/QAD.0b013e328333addf","article-title":"Adenovirus vector-specific T cells demonstrate a unique memory phenotype with high proliferative potential and coexpression of CCR5 and integrin alpha4beta7","volume":"24","author":"Chakupurakal","year":"2010","journal-title":"AIDS"},{"key":"2024103012540464600_jphp12350-cit-0082","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"2024103012540464600_jphp12350-cit-0083","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"key":"2024103012540464600_jphp12350-cit-0084","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1128\/JVI.01157-10","article-title":"Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5","volume":"84","author":"Masek-Hammerman","year":"2010","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0085","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1084\/jem.20081786","article-title":"Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells","volume":"205","author":"Perreau","year":"2008","journal-title":"J Exp Med"},{"key":"2024103012540464600_jphp12350-cit-0086","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1210-1389","article-title":"Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine","volume":"16","author":"Nabel","year":"2010","journal-title":"Nat Med"},{"key":"2024103012540464600_jphp12350-cit-0087","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","article-title":"Immune responses to influenza virus infection","volume":"162","author":"Kreijtz","year":"2011","journal-title":"Virus Res"},{"key":"2024103012540464600_jphp12350-cit-0088","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"2024103012540464600_jphp12350-cit-0089","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/jvi.2.8.778-786.1968","article-title":"Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice","volume":"2","author":"Schulman","year":"1968","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0090","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","article-title":"Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells","volume":"148","author":"Hashimoto","year":"1983","journal-title":"J Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0091","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N Engl J Med"},{"key":"2024103012540464600_jphp12350-cit-0092","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of neuraminidase antibody on Hong Kong influenza","volume":"1","author":"Monto","year":"1973","journal-title":"Lancet"},{"key":"2024103012540464600_jphp12350-cit-0093","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/jcm.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J Clin Microbiol"},{"key":"2024103012540464600_jphp12350-cit-0094","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00705-002-0870-y","article-title":"Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A\/HK\/1\/68 (H3N2)","volume":"147","author":"Tang","year":"2002","journal-title":"Arch Virol"},{"key":"2024103012540464600_jphp12350-cit-0095","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1128\/JVI.02667-05","article-title":"Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity","volume":"80","author":"Krause","year":"2006","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0096","doi-asserted-by":"crossref","first-page":"e18314","DOI":"10.1371\/journal.pone.0018314","article-title":"Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin","volume":"6","author":"Weaver","year":"2011","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0097","doi-asserted-by":"crossref","first-page":"e9812","DOI":"10.1371\/journal.pone.0009812","article-title":"Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret","volume":"5","author":"Rao","year":"2010","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0098","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.vaccine.2013.01.023","article-title":"Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-gamma T cell responses in humans","volume":"31","author":"Peters","year":"2013","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0099","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"2024103012540464600_jphp12350-cit-0100","doi-asserted-by":"crossref","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS Pathog"},{"key":"2024103012540464600_jphp12350-cit-0101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"2024103012540464600_jphp12350-cit-0102","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"2024103012540464600_jphp12350-cit-0103","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"J Clin Invest"},{"key":"2024103012540464600_jphp12350-cit-0104","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"2024103012540464600_jphp12350-cit-0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"2024103012540464600_jphp12350-cit-0106","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.1192517","article-title":"Induction of broadly neutralizing H1N1 influenza antibodies by vaccination","volume":"329","author":"Wei","year":"2010","journal-title":"Science"},{"key":"2024103012540464600_jphp12350-cit-0107","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024103012540464600_jphp12350-cit-0108","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"2024103012540464600_jphp12350-cit-0109","doi-asserted-by":"crossref","first-page":"e1000796","DOI":"10.1371\/journal.ppat.1000796","article-title":"Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog"},{"key":"2024103012540464600_jphp12350-cit-0110","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0111","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/irv.12013","article-title":"Advances in the development of universal influenza vaccines","volume":"7","author":"Gilbert","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"2024103012540464600_jphp12350-cit-0112","doi-asserted-by":"crossref","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med"},{"key":"2024103012540464600_jphp12350-cit-0113","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus-M2 protein is an integral membrane-protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"2024103012540464600_jphp12350-cit-0114","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0115","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"2024103012540464600_jphp12350-cit-0116","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/jvi.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0117","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine","volume":"27","author":"Fiers","year":"2009","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0118","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"2024103012540464600_jphp12350-cit-0119","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0120","doi-asserted-by":"crossref","first-page":"e28445","DOI":"10.1371\/journal.pone.0028445","article-title":"Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice","volume":"6","author":"Wolf","year":"2011","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0121","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1016\/j.vaccine.2012.03.021","article-title":"Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice","volume":"30","author":"Zhou","year":"2012","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0122","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1012199108","article-title":"Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus","volume":"108","author":"Song","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024103012540464600_jphp12350-cit-0123","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/mt.2014.33","article-title":"Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection","volume":"22","author":"Kim","year":"2014","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0124","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0125","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0126","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.vaccine.2008.02.047","article-title":"Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies","volume":"26","author":"Lo","year":"2008","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0127","doi-asserted-by":"crossref","first-page":"e13162","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses","volume":"5","author":"Price","year":"2010","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0128","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1128\/JVI.03101-13","article-title":"Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model","volume":"88","author":"Price","year":"2014","journal-title":"J Virol"},{"key":"2024103012540464600_jphp12350-cit-0129","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1038\/mt.2010.202","article-title":"A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge","volume":"18","author":"Zhou","year":"2010","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/mt.2012.248","article-title":"Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus","volume":"21","author":"Zhou","year":"2013","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0131","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nri2054","article-title":"Scientific barriers to developing vaccines against avian influenza viruses","volume":"7","author":"Subbarao","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2024103012540464600_jphp12350-cit-0132","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1099\/0022-1317-47-2-449","article-title":"Quantification of influenza virus messenger RNAs","volume":"47","author":"Tekamp","year":"1980","journal-title":"J Gen Virol"},{"key":"2024103012540464600_jphp12350-cit-0133","doi-asserted-by":"crossref","first-page":"e1190","DOI":"10.1371\/journal.pone.0001190","article-title":"Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets","volume":"2","author":"Heiny","year":"2007","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0134","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0140-6736(83)92297-3","article-title":"Declining T-cell immunity to influenza, 1977\u201382","volume":"2","author":"McMichael","year":"1983","journal-title":"Lancet"},{"key":"2024103012540464600_jphp12350-cit-0135","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2024103012540464600_jphp12350-cit-0136","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri2368","article-title":"The known unknowns of antigen processing and presentation","volume":"8","author":"Vyas","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2024103012540464600_jphp12350-cit-0137","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1586\/erv.10.132","article-title":"Cytolytic CD4(+) T cells in viral immunity","volume":"9","author":"Soghoian","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"2024103012540464600_jphp12350-cit-0138","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"2024103012540464600_jphp12350-cit-0139","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"key":"2024103012540464600_jphp12350-cit-0140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"key":"2024103012540464600_jphp12350-cit-0141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/cis327","article-title":"Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans","volume":"55","author":"Lillie","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Pt 8","key":"2024103012540464600_jphp12350-cit-0143","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-70-8-2111","article-title":"Biological and genetic evolution of the nucleoprotein gene of human influenza A viruses","volume":"70","author":"Altmuller","year":"1989","journal-title":"J Gen Virol"},{"key":"2024103012540464600_jphp12350-cit-0144","first-page":"3478","article-title":"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","volume":"118","author":"Lee","year":"2008","journal-title":"J Clin Invest"},{"key":"2024103012540464600_jphp12350-cit-0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.virol.2010.05.002","article-title":"Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes","volume":"405","author":"Singh","year":"2010","journal-title":"Virology"},{"key":"2024103012540464600_jphp12350-cit-0146","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.vaccine.2012.11.047","article-title":"Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus","volume":"31","author":"Boyd","year":"2013","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0147","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1016\/j.vaccine.2007.07.035","article-title":"Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein","volume":"25","author":"Roy","year":"2007","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0148","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.4049\/jimmunol.0903808","article-title":"Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway","volume":"184","author":"DiMenna","year":"2010","journal-title":"J Immunol"},{"key":"2024103012540464600_jphp12350-cit-0149","doi-asserted-by":"crossref","first-page":"e48322","DOI":"10.1371\/journal.pone.0048322","article-title":"A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years","volume":"7","author":"Antrobus","year":"2012","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/mt.2013.162","article-title":"Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses","volume":"22","author":"Antrobus","year":"2013","journal-title":"Mol Ther"},{"key":"2024103012540464600_jphp12350-cit-0151","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/590434","article-title":"Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial","volume":"198","author":"Holland","year":"2008","journal-title":"J Infect Dis"},{"key":"2024103012540464600_jphp12350-cit-0152","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1016\/j.vaccine.2009.08.053","article-title":"Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses","volume":"27","author":"Price","year":"2009","journal-title":"Vaccine"},{"key":"2024103012540464600_jphp12350-cit-0153","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/08828240260066242","article-title":"Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines","volume":"15","author":"Murphy","year":"2002","journal-title":"Viral Immunol"},{"key":"2024103012540464600_jphp12350-cit-0154","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/srep01443","article-title":"Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1","volume":"3","author":"Lambe","year":"2013","journal-title":"Sci Rep"},{"key":"2024103012540464600_jphp12350-cit-0155","doi-asserted-by":"crossref","first-page":"e75460","DOI":"10.1371\/journal.pone.0075460","article-title":"Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS ONE"},{"key":"2024103012540464600_jphp12350-cit-0156","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood"},{"key":"2024103012540464600_jphp12350-cit-0157","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2010-03-272336","article-title":"CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells","volume":"117","author":"Bassett","year":"2011","journal-title":"Blood"},{"key":"2024103012540464600_jphp12350-cit-0158","doi-asserted-by":"publisher","DOI":"10.5772\/22821","article-title":"Harnessing the potential of adenovirus vectored vaccines","volume-title":"Viral Gene Therapy","author":"Holst","year":"2011"},{"key":"2024103012540464600_jphp12350-cit-0159","doi-asserted-by":"crossref","first-page":"e1001142","DOI":"10.1371\/journal.ppat.1001142","article-title":"Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X","volume":"6","author":"Bradshaw","year":"2010","journal-title":"PLoS Pathog"},{"key":"2024103012540464600_jphp12350-cit-0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"2024103012540464600_jphp12350-cit-0161","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","article-title":"Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors","volume":"116","author":"Alba","year":"2010","journal-title":"Blood"},{"key":"2024103012540464600_jphp12350-cit-0162","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"key":"2024103012540464600_jphp12350-cit-0163","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/erv.13.35","article-title":"Immunological assessment of influenza vaccines and immune correlates of protection","volume":"12","author":"Reber","year":"2013","journal-title":"Expert Rev Vaccines"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12350","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12350","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/67\/3\/382\/60229048\/jphp12350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/67\/3\/382\/60229048\/jphp12350.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:19:29Z","timestamp":1730312369000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/67\/3\/382\/6128079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,1]]},"references-count":163,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,1]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.12350","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"value":"2042-7158","type":"electronic"},{"value":"0022-3573","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,3]]},"published":{"date-parts":[[2015,3,1]]}}}